tirzepatide covered by cvs caremark Getting Zepbound or Mounjaro Approved Through π¨ CVS Caremark Finally Added
Description
Phase 3 data: TRIUMPH-4 The TRIUMPH-4 trial focused on participants with osteoarthritis and demonstrated an average weight loss of 71.2 pounds along with significant improvements in joint pain and function
Off-label use, such as splitting the dose or microdosing, should only be done under the guidance of a licensed healthcare professional
This proactive approach prevents the worst side effects
This strategy is especially pertinent given the availability of current-generation anti-obesity drugs (AOMs), which can cause weight reduction of more than 10%
